Published in Clinical Trials Week, June 4th, 2007
"This is an important trial because it will provide additional information on the optimal timing for use of MyVax(R) personalized immunotherapy following treatment with the current standard of care for patients with fNHL," said Julie Vose,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.